APA (7th ed.) Citation

E, K., R, F., P, E., DE, F., R, v. V., J, B., . . . F, M. (2007). Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open-label extension analysis. Arthritis & Rheumatism, 56(12), 3896. https://doi.org/10.1002/art.23059

Chicago Style (17th ed.) Citation

E, Keystone, et al. "Safety and Efficacy of Additional Courses of Rituximab in Patients with Active Rheumatoid Arthritis: An Open-label Extension Analysis." Arthritis & Rheumatism 56, no. 12 (2007): 3896. https://doi.org/10.1002/art.23059.

MLA (9th ed.) Citation

E, Keystone, et al. "Safety and Efficacy of Additional Courses of Rituximab in Patients with Active Rheumatoid Arthritis: An Open-label Extension Analysis." Arthritis & Rheumatism, vol. 56, no. 12, 2007, p. 3896, https://doi.org/10.1002/art.23059.